AMN Healthcare account plan
Healthcare talent solutions provider
At a glance
AMN Healthcare provides US healthcare staffing, managed services and workforce technology: $2,730.4 million FY2025 revenue, 2,664 corporate staff.
AMN Healthcare Services, Inc. provides "total talent solutions" to US hospitals and other care settings: nurse, allied, locum tenens and leadership staffing, managed services programs (MSP), vendor management systems (VMS), recruitment process outsourcing, workforce consulting and medical language interpretation. Substantially all revenue is in the US, concentrated in California, New York and Texas, and more than half of temporary assignments are at acute-care hospitals. FY2025 revenue was $2,730.4 million, down 8% from $2,983.8 million, with a net loss of $(95.7) million after a $109.5 million goodwill impairment. It had 2,664 corporate team members at December 31, 2025, with offices in Dallas, San Diego, Boca Raton and Atlanta, and Kaiser Foundation Hospitals accounted for about 22% of consolidated revenue.
Business units
Nurse and Allied Solutions
60% of 2025 revenue ($1,647.3 million)Travel nurse staffing, international nurse staffing and placement, rapid response and labor disruption (strike) staffing, local staffing, allied staffing including schools, and revenue cycle solutions. Revenue fell 9% in 2025 on 14% fewer travelers, then rose 27% to $460.0 million in Q3 2026 on 16% more travelers and labor disruption reserve releases. A majority of placements are made under managed services.
Physician and Leadership Solutions
26% of 2025 revenue ($696.4 million)Locum tenens staffing of physicians, dentists, advanced practice providers and CRNAs, physician permanent placement, interim leadership and executive search. Revenue fell 4% in 2025 and the segment took a $109.5 million goodwill impairment; in Q3 2026 revenue was $171.2 million (-4%), with locum tenens down 5% and search up 15%. Locum tenens is going through the same process and technology transformation as Nurse and Allied.
Technology and Workforce Solutions
14% of 2025 revenue ($386.7 million)AMN Language Services (medical interpretation used by more than 2,700 hospitals), SaaS VMS (ShiftWise Flex, Medefis, b4health), workforce optimization and RPO. Revenue fell 12% in 2025 and 9% to $86.1 million in Q3 2026 on language pricing pressure and lower VMS utilization; gross margin was 47.7% in Q3 2026.
Strategic priorities
- Total talent partner model
- AMN cross-sells staffing, talent planning and technology to grow client relationships and recurring revenue; more than half of its pipeline was MSP for the third quarter in a row in Q3 2026.
- Automation and AI in recruiting
- The company is "increasing investments in automation and AI-enabled technology" in recruiting, credentialing and candidate engagement, and credits process automation and 24/7 operations for higher fill rates.
- Locum tenens turnaround
- A growth acceleration program modelled on Nurse and Allied aims to return locum tenens to growth in 2027 by competing across MSP, vendor-neutral, direct and third-party channels.
- Language services margin recovery
- A tiered, global service model rolls out by the end of the first quarter of 2027, with language gross margin in the mid-30s and a path back toward 40%.
- Retaining Kaiser
- The Kaiser contract runs to the end of 2026 and is in a competitive RFP; Kaiser was about 22% of 2025 revenue and 32% of Nurse and Allied revenue.
Latest results
In Q3 2026 (quarter ended September 30, 2026) revenue was $717.3 million, up 13% from $634.5 million and 7% sequentially, or up 6% excluding labor disruption. Adjusted EBITDA was $93.6 million, a 13.0% margin, helped by a $51 million favorable reserve adjustment for past strike events; net income was $33.4 million. Nine-month revenue rose 40% to $2,768.9 million on large labor disruption events. Q3 operating cash flow was ($88 million) as strike deposits were refunded, and cash was $256 million with leverage of 1.3x. For Q4 2026 AMN guides to revenue of $655-670 million (10-12% lower year on year as labor disruption revenue falls to $5 million from $124 million) and an adjusted EBITDA margin of 5.8-6.3%.
Investments and deals
- Workforce technology platforms
- WorkWise (demand forecasting, predictive scheduling, workforce and vendor management), the ShiftWise Flex VMS and the AMN Passport clinician app, which passed 400,000 users by Q2 2026.
- Acquisitions of Jaide Health and Essential Brand
- In 2026 AMN acquired Jaide Health for AI-enabled pre- and post-visit interpretation and the Essential Brand Leadership Assessment for search; the two deals cost $3 million.
- Sale of Smart Square
- The scheduling software was sold on July 1, 2025 for $65.3 million cash plus a $10.0 million note.
- Debt refinancing
- In October 2025 AMN issued $400.0 million of 6.500% notes due 2031 to redeem $500.0 million of 2027 notes, and cut the revolver to $450.0 million, extended to 2030.
Challenges and risks
- Client concentration
- Kaiser Foundation Hospitals was about 22% of 2025 revenue, its contract ends with 2026 and is in a competitive RFP, and healthcare consolidation raises concentration risk.
- Language services pricing
- Language services pricing fell 9% in Q3 2026 on increased competition, and pricing pressure is expected to moderate only to mid single digits in 2027.
- Immigration delays
- Embassy visa appointment delays slow international nurse placements and will lower the run rate into 2027.
- Volatile strike revenue
- Labor disruption revenue is unpredictable: it drove 2026 growth but Q4 2026 guidance assumes only $5 million against $124 million a year earlier.
- Regulatory and technology risks
- The 10-K names challenges to the independent-contractor classification of locum tenens and interpreters, cybersecurity incidents and AI use as risks.
What leadership says
“We are encouraged by the continued growth in nursing and allied staffing. Demand strengthened during the third quarter and through October and our team is delivering for our clients through faster recruiting, automation, and around-the-clock execution.”
“We see healthcare organizations taking a broader view of their workforce.”
“Bill rates overall have been stable for 18 months.”
“widen our capital allocation aperture”
Where a supplier can help
- AI and automation for recruiting
- AMN's investment in automation and AI-enabled recruiting, credentialing and candidate engagement favours vendors of recruiting automation, AI and data tooling.
- Tooling for the locum tenens turnaround
- The locum tenens growth acceleration program needs faster processes across vendor-neutral and third-party channels, where AMN says it is not yet fast enough.
- Global interpreter workforce
- The tiered, global language service model aimed at restoring margin opens room for interpreter sourcing, telecom and workforce management partners.
- Security and compliance
- Cybersecurity incidents, AI use and contractor classification are named risks, relevant to security, governance and compliance providers.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like AMN Healthcare?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- AMN Healthcare Services, Inc. Annual Report on Form 10-K for fiscal year 2025
- AMN Healthcare is a US provider of "total talent solutions" for healthcare: nurse, allied, locum tenens and leadership staffing, managed services programs (MSP), vendor management systems (VMS), recruitment process outsourcing, workforce consulting and medical language interpretation. Substantially all revenue is in the US, mostly California, New York and Texas.
- FY2025 revenue was $2,730.4 million, down 8% from $2,983.8 million in 2024; net loss was $(95.7) million (2024: $(147.0) million), after a $109.5 million goodwill impairment in physician and leadership solutions and an $18.3 million intangible impairment.
- Three segments: Nurse and Allied Solutions (60% of revenue), Physician and Leadership Solutions (26%) and Technology and Workforce Solutions (14%). Gross margin fell to 28.3% from 30.8%.
- About 48% of revenue flowed through MSP relationships. Spend under management was about $3.3 billion: $1.8 billion through MSPs and $1.4 billion through VMS programs.
- Kaiser Foundation Hospitals and its affiliates accounted for about 22% of consolidated revenue and 32% of Nurse and Allied revenue.
- Labor disruption (strike) staffing added $127.9 million of revenue in 2025, partly offsetting a 14% fall in average travelers on assignment.
- AMN is investing in technology: the WorkWise platform, the ShiftWise Flex VMS, the AMN Passport app (more than 340,000 registered users as of January 2026) and automation and AI in recruiting and credentialing. Capex fell to $35.6 million from $80.9 million.
- Portfolio and balance sheet: Smart Square scheduling software was sold on July 1, 2025 for $65.3 million cash plus a $10.0 million note. In October 2025, $400.0 million of 6.500% notes due 2031 refinanced the $500.0 million of 2027 notes. The revolver was cut to $450.0 million and extended to 2030.
- Main risks: client concentration and healthcare consolidation, intermediaries, pricing pressure, independent-contractor classification, cybersecurity and AI, and leverage covenants. The company had 2,664 corporate team members at year-end.
- AMN Healthcare Form 10-Q for the quarter ended September 30, 2026
- Q3 2026 revenue was $717.3 million, up 13% from $634.5 million. Nine-month revenue was $2,768.9 million, up 40%, driven by labor disruption (strike) work.
- Nurse and Allied Solutions revenue rose 27% to $460.0 million. Higher average travelers on assignment (+16%) added $53.3 million, and labor disruption reserve releases and billing settlements added $47.0 million. The segment was 73% of nine-month revenue.
- Physician and Leadership Solutions fell 4% to $171.2 million; locum tenens fell $7.2 million (5%) on 8% fewer days filled.
- Technology and Workforce Solutions fell 9% to $86.1 million: language services fell 8% on lower pricing and VMS fell 11%.
- Gross margin rose to 31.9% from 29.1%, driven by reserve releases. Segment gross margins were 30.9% (Nurse and Allied), 27.0% (Physician and Leadership) and 47.7% (Technology and Workforce).
- MSP arrangements were about 49% of Q3 revenue and 62% of nine-month revenue.
- Liquidity: nothing was drawn on the $450.0 million revolver, with $350.0 million of 2029 notes and $400.0 million of 2031 notes outstanding. Nine-month operating cash flow was $285.0 million and DSO was 54 days.
- Trends: strong travel nurse and allied demand with stable bill rates. International nurse is slowed by immigration policy headwinds. Language pricing pressure continues, and VMS declined on client-specific dynamics.
- AMN Healthcare Announces Third Quarter 2026 Results (earnings release, 8-K Exhibit 99.1)
- Q3 2026 revenue was $717 million (+13% year on year, +7% sequentially), with adjusted EBITDA of $94 million (13.0% margin, +63%). GAAP diluted EPS was $0.83 and adjusted EPS $1.16, against $0.39 a year earlier.
- Revenue and earnings beat guidance, driven by travel nurse and allied and by a labor disruption reserve release.
- Nurse and Allied Solutions revenue was $460 million (+27%): travel nurse +19%, allied +11%, labor disruption $59 million (vs $12 million a year earlier).
- Physician and Leadership Solutions revenue was $171 million (-4%): locum tenens $138 million (-5%), search +15%.
- Technology and Workforce Solutions revenue was $86 million (-9%): language services $69 million (-8%), VMS $15 million (-11%).
- Cash was $256 million and leverage 1.3x. Operating cash flow was ($88 million) in Q3 because most strike-related client deposits were refunded. AMN repurchased 250,685 shares for $8.4 million.
- Q4 2026 guidance: revenue of $655-670 million (10-12% lower year on year, as labor disruption revenue drops to $5 million from $124 million) and adjusted EBITDA margin of 5.8-6.3%. Nurse and Allied is guided up 13-15% excluding labor disruption.
- CEO Cary Grace: healthcare organizations "increasingly want better visibility and more strategic management of their total workforce".
- AMN Healthcare Q3 2026 earnings call transcript
- Q3 2026 earnings call (November 5, 2026) with CEO Cary Grace and CFO/COO Brian Scott. Revenue was $717 million (+13%, or +6% excluding labor disruption), including a $51 million favorable reserve adjustment for past labor disruption events.
- Grace says clients now want "better insights and visibility into demand, supply and performance across their workforce". Five businesses are back to growth, and the others have a path back to growth in 2027.
- Nurse and Allied volume was +16% (travel nurse +21%, allied +12%). Nursing and allied demand is up 70% from February to October, and AMN is "on track to have the highest levels of productivity in nurse and allied that we have ever had".
- Bill rates have been stable for 18 months. Clinicians are starting to hold out for higher rates, which Grace sees as a precursor to rate increases in 2027.
- International nurse will add over $150 million of revenue growth in 2026, but embassy visa appointment delays will constrain 2027 placements.
- Locum tenens is running the same process and technology transformation as Nurse and Allied did, aiming for growth in 2027. Language services pricing fell 9%, and a global interpreter workforce should restore margin in the first half of 2027.
- The Kaiser contract runs to the end of 2026 and is in a competitive RFP; AMN feels "very well positioned". More than half of the pipeline is MSP for the third quarter in a row.
- Q4 guidance is revenue of $655-670 million with $5 million of labor disruption revenue, and an adjusted EBITDA margin of 5.8-6.3%.
- AMN Healthcare Q2 2026 earnings call transcript
- Q2 2026 earnings call (August 6, 2026) with CEO Cary Grace and CFO/COO Brian Scott. Revenue was $673 million, 6% above the top of guidance and +2% year on year. Adjusted EBITDA was $73 million (10.9% margin, +26%) and cash $362 million.
- About $27 million of non-recurring labor disruption true-ups and reserve items lifted revenue and margins. Without them, the EBITDA margin would still have been at the top of the 6.7-7.2% guidance.
- Travel nurse volume grew 6% and allied 7%, the fastest in 4 years. Travel nurse orders were up about 40% year on year in early August. International nurse revenue was +23%.
- Search revenue grew 27%. Locum tenens ($131 million, -8%) is being re-engineered to return to growth in 2027.
- Language services ($70 million, -8%) faces price competition. AMN acquired Jaide Health for AI-enabled pre- and post-visit interpretation, and Essential Brand Leadership Assessment for search. The two deals cost $3 million.
- Passport passed 400,000 users (+33%), with monthly active users up more than 50%.
- The Kaiser contract runs to the end of 2026 and is in an RFP. Lower leverage lets AMN be "an active participant" in industry consolidation.
- Q3 guidance was revenue of $640-655 million and an adjusted EBITDA margin of 6.5-7%.
Questions about AMN Healthcare
What does AMN Healthcare do?
AMN provides healthcare staffing (nurse, allied, locum tenens, leadership), managed services programs, vendor management systems, recruitment process outsourcing and medical language interpretation to US hospitals and care settings.
What is AMN Healthcare's revenue?
FY2025 revenue was $2,730.4 million, down 8%. Q3 2026 revenue was $717.3 million, up 13%, and nine-month 2026 revenue was $2,768.9 million.
How many employees does AMN Healthcare have?
AMN had 2,664 corporate team members at December 31, 2025; in Q4 2025 an average of 8,722 nurses, allied and other healthcare professionals also worked for it.
Who leads AMN Healthcare?
Caroline S. (Cary) Grace is President and CEO, Brian M. Scott is CFO and COO, and Mark G. Foletta is Chairman of the Board.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)